Products
Enerbay Pharma is dedicated to curating a specialized array of patented medications, strategically designed to make a significant impact on the global healthcare arena.
Overview
Quis sit duis nulla at etiam scelerisque dignissim amet sit nec et in ultrices interdum viverra felis, consectetur a libero, habitant mi nunc leo.
Mattis tristique tincidunt scelerisque neque felis non sed sed dignissim sit ornare fermentum velit amet mauris eget dui scelerisque augue cum tellus aliquet donec leo, euismod id mattis eu, tortor sit eget commodo egestas tincidunt tortor justo, porta pulvinar at.
Our Brands
Specialty Medications
Enerbay Pharma is dedicated to curating a specialized array of patented medications, strategically designed to make a significant impact on the global healthcare arena. Our primary areas of focus encompass dermatology, ophthalmology, and oncology, where we are committed to optimizing patient outcomes by addressing medical gaps and introducing convenience through unique dosage forms. Our initiatives span the pharmaceutical spectrum, ranging from licensing promising clinical candidates in various stages of development to securing rights to established patented products already available in the market. Our dedication goes beyond the mere introduction of medications; it revolves around reshaping the healthcare landscape through innovative solutions and compassionate care. Enerbay Pharma stands as a beacon of progress, seamlessly uniting cutting-edge scientific advancements, patient-centered approaches, and an unwavering commitment to enhancing lives on a global scale.
Generic Medications
Within our expansive product range, we cover a wide spectrum of dosage forms, ensuring that our offerings cater to various preferences and needs. This includes an array of options such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Our versatile portfolio, comprising over 2000 distinct molecules, encompasses an impressive array of therapeutic domains. These therapeutic domains encompass an impressive array of areas including but not limited to psychiatry, anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental, and nutritionals.
In the international arena, Enerbay Pharma has managed to establish itself as a prominent player within these therapeutic categories. Our unwavering commitment to quality, accessibility, and innovation has positioned us among the forefront of pharmaceutical companies, serving as a testament to our dedication to enhancing healthcare across the globe.
Over-the-Counter Medications
Our range expands to encompass a diverse selection of over-the-counter (OTC) and consumer healthcare products. Among these, our notable flagship OTC brands, including Faringosept (targeting sore throat relief), Revital (offering essential vitamin supplementation), and Volini (providing effective topical analgesia), command a global presence across multiple countries. Additionally, our lineup features other prominent brands such as Coldact & Flustat (designed to address symptoms of cold and flu), Brustan, Painamol & Paduden (offering analgesic solutions), Aspenter, Aspacardin, Nudrate & Fortifikat (serving as lifestyle-enhancing OTC options), Gestid (promoting digestive well-being), and Chericof (offering effective cough relief). These brands redefine their respective categories, showcasing our commitment to delivering innovative, impactful, and consumer-focused solutions that cater to a wide spectrum of healthcare needs.
Active Pharmaceutical Ingredients
Exceeding a count of 300, our comprehensive API list serves both our internal requirements and extends its reach to customers spanning across more than 60 countries. The production of our APIs takes place in facilities accredited by the World Health Organization (WHO) located in India. Our API portfolio encompasses a diverse spectrum, inclusive of both generics and intricate APIs. This range covers a broad spectrum, including those demanding isolated production settings. Noteworthy inclusions involve anti-cancer agents, peptides, steroids, sex hormones, and controlled substances. Notably, our repertoire incorporates raw materials derived from poppy, central to the production of opiate-based analgesics. These materials are available both as Narcotic Raw Materials (NRM) and APIs. Our diverse offerings span from bulk actives to intermediates, extending to encompass the provision of custom synthesis services.
Anti-Retro Viral Medications
Our selection encompasses a diverse range of ARV medicines that are prequalified by the World Health Organization (WHO). Our primary objective centers on enhancing accessibility and affordability. This commitment is exemplified by our provision of ARVs to various National AIDS treatment programs across Africa. Since 2004, our partnership with the Clinton Health Access Initiative (CHAI) has been instrumental in reducing the cost of the triple drug cocktail for consortium partners in Africa and beyond.
Our portfolio comprises bio-equivalent ARV medicines as well as Active Pharmaceutical Ingredients (APIs), all meticulously produced within our advanced WHO-prequalified manufacturing facilities located in India. Additionally, we boast a PIC/S-approved manufacturing facility in South Africa and another facility in Russia. Our product range encompasses a multitude of first-line and second-line Highly Active Antiretroviral Therapy (HAART) regimens, reflecting our resolute commitment to the global fight against HIV/AIDS. Through these comprehensive efforts, we endeavor to make a substantial contribution to the ongoing battle against this pressing health challenge.
